Latest news with #BrettMIcahn
Yahoo
3 days ago
- Business
- Yahoo
Bausch + Lomb Announces Board Changes
VAUGHAN, Ontario, August 18, 2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the Amended and Restated Director Appointment and Nomination Agreement, dated as of June 21, 2022, by and among the company and Mr. Carl C. Icahn and certain of his affiliates, terminated pursuant to its terms when the Icahn group's net long position in the common shares of Bausch + Lomb's parent company, Bausch Health Companies Inc., fell below the required threshold. In connection with the termination, Brett M. Icahn and Gary Hu have resigned from the Bausch + Lomb Board of Directors. "I appreciate Brett and Gary's valuable contributions to the company over the past three years, and wish them well going forward," said Brent Saunders, chairman and CEO, Bausch + Lomb. About Bausch + LombBausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit and connect with us on Facebook, Instagram, LinkedIn, X and YouTube. © 2025 Bausch + Lomb View source version on Contacts Media Contact: Chris (848) 360-1100 Investor Contact: George (877) 354-3705 (toll free)(908) 927-0735
Yahoo
3 days ago
- Business
- Yahoo
Bausch Health (BHC) Climbs 45% on Insider Buying
We recently published . Bausch Health Companies Inc. (NYSE:BHC) is one of the last week's top performers. Bausch Health jumped by 45.04 percent week-on-week, on a combination of bargain-hunting and mirroring an insider purchase last Friday. In a regulatory filing, Bausch Health Companies Inc. (NYSE:BHC) said that Paulson Capital Inc. and its affiliates acquired 34.7 million of its shares from Carl C. Icahn and affiliates, effectively boosting its total ownership to 19.13 percent. Following the transaction that saw the sellers' shares fall below the threshold to earn a board seat, the Icahn Group officially exited Bausch Health Companies Inc.'s (NYSE:BHC) higher management. Copyright: nimon / 123RF Stock Photo Additionally, Brett M. Icahn and Steven D. Miller have resigned from the company's board of directors. In recent news, Bausch Health Companies Inc. (NYSE:BHC) expanded its attributable net income by 1,380 percent in the second quarter of the year to $148 million from only $10 million in the same period last year. Revenues also grew by 5 percent to $2.53 billion from $2.4 billion. While we acknowledge the potential of BHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Sign in to access your portfolio
